These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2378340)

  • 1. Toxic effects associated with the administration of deferoxamine in the premature baboon with hyaline membrane disease.
    deLemos RA; Roberts RJ; Coalson JJ; deLemos JA; Null DM; Gerstmann DR
    Am J Dis Child; 1990 Aug; 144(8):915-9. PubMed ID: 2378340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation.
    Delemos RA; Coalson JJ; Gerstmann DR; Null DM; Ackerman NB; Escobedo MB; Robotham JL; Kuehl TJ
    Pediatr Res; 1987 Jun; 21(6):594-602. PubMed ID: 3299231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D; Maeta H; Raju TN; John E; Bhat R; Go M; Dahiya U; Roberson Y; Yamin A; Narula A
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen toxicity in the premature baboon with hyaline membrane disease.
    Delemos RA; Coalson JJ; Gerstmann DR; Kuehl TJ; Null DM
    Am Rev Respir Dis; 1987 Sep; 136(3):677-82. PubMed ID: 3307571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-frequency oscillatory ventilation versus intermittent mandatory ventilation: early hemodynamic effects in the premature baboon with hyaline membrane disease.
    Kinsella JP; Gerstmann DR; Clark RH; Null DM; Morrow WR; Taylor AF; deLemos RA
    Pediatr Res; 1991 Feb; 29(2):160-6. PubMed ID: 2014152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oliguria in the premature baboon with hyaline membrane disease: a manifestation of multisystem immaturity?
    Delemos J; Dryer G; Gerstmann D; Delemos R
    J Perinatol; 1989 Mar; 9(1):19-25. PubMed ID: 2651593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late surfactant treatments in baboon model of hyaline membrane disease.
    Maeta H; Vidyasagar D; Raju TN; Bhat R; Matsuda H
    Pediatrics; 1988 Feb; 81(2):277-83. PubMed ID: 3340477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ventilatory technique on pulmonary baroinjury in baboons with hyaline membrane disease.
    Gerstmann DR; deLemos RA; Coalson JJ; Clark RH; Wiswell TE; Winter DC; Kuehl TJ; Meredith KS; Null DM
    Pediatr Pulmonol; 1988; 5(2):82-91. PubMed ID: 3065708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent ductus arteriosus during high-frequency ventilation for hyaline membrane disease.
    Yoder BA; Kuehl TJ; de Lemos RA; Null DM; Ackerman NB
    Crit Care Med; 1987 Jun; 15(6):587-90. PubMed ID: 3552446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tolazoline in severe hyaline membrane disease.
    McIntosh N; Walters RO
    Arch Dis Child; 1979 Feb; 54(2):105-10. PubMed ID: 434884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
    Shimada S; Raju TN; Bhat R; Maeta H; Vidyasagar D
    Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-frequency ventilation compared to conventional positive-pressure ventilation in the treatment of hyaline membrane disease in primates.
    Bell RE; Kuehl TJ; Coalson JJ; Ackerman NB; Null DM; Escobedo MB; Yoder BA; Cornish JD; Nalle L; Skarin RM
    Crit Care Med; 1984 Sep; 12(9):764-8. PubMed ID: 6380939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary interstitial emphysema in the premature baboon with hyaline membrane disease.
    Ackerman NB; Coalson JJ; Kuehl TJ; Stoddard R; Minnick L; Escobedo MB; Null DM; Robotham JL; deLemos R
    Crit Care Med; 1984 Jun; 12(6):512-6. PubMed ID: 6373147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal shunting and effective systemic blood flow following single dose surfactant treatment in the premature baboon with hyaline membrane disease.
    Kinsella JP; Gerstmann DR; Gong AK; Taylor AF; deLemos RA
    Biol Neonate; 1991; 60(5):283-91. PubMed ID: 1790252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning.
    Tenenbein M; Kowalski S; Sienko A; Bowden DH; Adamson IY
    Lancet; 1992 Mar; 339(8795):699-701. PubMed ID: 1347583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaline membrane disease of the premature.
    Kuehl TJ
    Trans Assoc Life Insur Med Dir Am; 1985; 67():62-5. PubMed ID: 3852567
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary toxicity of deferoxamine in iron-poisoned mice.
    Adamson IY; Sienko A; Tenenbein M
    Toxicol Appl Pharmacol; 1993 May; 120(1):13-9. PubMed ID: 8511775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of parenteral deferoxamine for acute iron poisoning.
    Howland MA
    J Toxicol Clin Toxicol; 1996; 34(5):491-7. PubMed ID: 8800186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity.
    DeBoer DA; Clark RE
    Ann Thorac Surg; 1992 Mar; 53(3):412-8. PubMed ID: 1540057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron chelation therapy with deferoxamine in Cooley anemia.
    Cohen A; Schwartz E
    J Pediatr; 1978 Apr; 92(4):643-7. PubMed ID: 633031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.